SMMC is accredited by
The Joint Commission
One of 93 hospitals nationwide
so designated by the
American Nurses Credentialing Center
SMMC's Cancer Program has received
Accreditation with Commendation,
the highest level awarded
The Southern Maine Medical Center (SMMC) Sleep Lab has moved to the Goodall Health Center located at 2 Livewell Drive in Kennebunk, into the suite previously occupied by Goodall Hospital’s Sleep Institute. Beginning on June 11, all sleep studies for Goodall and SMMC patients will be performed at our new location. Chris Hughes, MD, PhD, Robert McArdle, DO and Usha Nalamalapu, MD, FAASM... read more
At Southern Maine Medical Center’s (SMMC) annual Employee Recognition Dinner, Emergency department Nurse Lee Chick was named Caregiver of the Year. Chick is deeply respected by those who work with him for his exceptional care to patients, co-workers and community. He exemplifies the qualities of commitment, dedication and compassion that make an outstanding caregiver.
Chick... read more
Maine Ranked First in the Nation for Hospital Safety
Goodall Hospital and Southern Maine Medical Center (SMMC) are pleased to announce that they have both been honored with an “A” Hospital Safety Score by The Leapfrog Group, an independent national nonprofit run by employers and other large purchasers of health benefits. The A score was awarded... read more
Register by June 7 for a free t-shirt!
On June 29, Southern Maine Medical Center (SMMC) is hosting its 3rd Annual “Be Healthy” 5K Run/Walk to benefit the SMMC Center for Breast Care. The 5K race begins at 9 a.m.; followed by the walk at 10:00 a.m. on the eastern Trail adjacent to the medical center. According to breast cancer survivor and... read more
Crucial in the development of drugs, clinical trials are today delayed by the difficulty of recruiting participants. Decentralize and dematerialize, thanks to digital, could be the solution.
Why digitize clinical trials?
Lionel Bascles. - The organization of clinical trials has become more complex, time consuming and expensive. Recruiting appropriate participants is increasingly difficult, especially when it comes to treatments targeting very specific diseases that only affect small populations of patients cialisfr.fr
read more